Adaptive Individualized Modeling From Limited Clinical Data for Precise Anemia Management
It is challenging in practice to achieve a steady-state value for external human recombinant erythropoietin (EPO) dosage to be administrated to maintain Hemoglobin (Hb) level within the desired range of 11–12 g/dl based on population-based models for anemia management due to inter-and int...
Main Authors: | Affan Affan, Jacek M. Zurada, Tamer Inanc |
---|---|
Format: | Article |
Language: | English |
Published: |
IEEE
2021-01-01
|
Series: | IEEE Access |
Subjects: | |
Online Access: | https://ieeexplore.ieee.org/document/9520418/ |
Similar Items
-
Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen
by: Lena Klopp-Schulze, et al.
Published: (2020-03-01) -
Individual differences in voice adaptability are specifically linked to voice perception skill
by: Bestelmeyer, P.E.G, et al.
Published: (2021) -
Myocardial adaptation to hypoxia during nutritional anemia
by: Harden, John Wesley
Published: (2008) -
Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
by: Maddalena Centanni, et al.
Published: (2020-03-01) -
A Review of Cross Validation and Adaptive Model Selection
by: Syed, Ali R
Published: (2011)